MILAGROS P BUENAVENTURA
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry CAMP HILL, PA NPI 1780667402
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry PA Takeda Pharmaceuticals U.S.A., Inc. All categories
General Payments — all program years on this page
$1,581.33
- Category: General Payments
- Program years: PY2018–2020
- Record count: 118
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $147.77 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $147.77 | 8 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $53.37 | 3 |
| Otsuka America Pharmaceutical, Inc. | $31.13 | 2 |
| Teva Pharmaceuticals USA, Inc. | $25.71 | 1 |
| Alkermes, Inc. | $22.92 | 1 |
| Janssen Pharmaceuticals, Inc | $14.64 | 1 |
By program year
Records — PY2020 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 719315041 | Janssen Pharmaceuticals, Inc | $14.64 | 03/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736963533 | Alkermes, Inc. | $22.92 | 02/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 747139329 | Takeda Pharmaceuticals U.S.A., Inc. | $13.03 | 01/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 747139331 | Takeda Pharmaceuticals U.S.A., Inc. | $15.41 | 01/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 747139333 | Takeda Pharmaceuticals U.S.A., Inc. | $24.93 | 03/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 748695453 | Otsuka America Pharmaceutical, Inc. | $19.60 | 01/28/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 748695455 | Otsuka America Pharmaceutical, Inc. | $11.53 | 02/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 749475075 | Teva Pharmaceuticals USA, Inc. | $25.71 | 06/01/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.